The manufacturing and material records for the crown prt aortic pericardial heart valve, model # cna23, s/n # (b)(6) , as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a crown prt aortic pericardial heart valve at the time of manufacture and release.
|
Updated sections b4, d3, g1, g3, g6, h1, h2 (completed as a placeholder, no new information received),h3, h6 (corrected coding) based on the information available, it is not possible to draw a definitive conclusion for the reported event.However, from the document review performed, no manufacturing deficiencies were identified.As reported in the scientific literature, structural valve deterioration is the major cause of failure of bioprosthetic heart valves and the principal underlying pathologic process is cuspal calcification.Calcification can also cause stenosis due to cuspal stiffening.Calcific deposits are usually localized to cuspal tissue (intrinsic calcification).It is possible that the patient¿s clinical history and risk factors may have contributed to the structural valve deterioration observed in this crown valve.However, little clinical history was provided and a definitive root cause cannot be stated at this time.It should be noted that structural valve deterioration is listed as a possible adverse event in the crown ifu.The event is, therefore, a known inherent risk of the device.Since the device was discarded, no further investigation is possible at this time.The manufacturer attempted to retrieve additional information on the event but no further information was received to date.Should further information be provided in the future, an update to this reporting activity will be provided.
|